Abstract

A short review on pharmacokinetics-pharmacodynamics (PK-PD) presented below aims to show the evolution of some concepts and ideas in this field. Some of them are developed in more detail in the papers of this issue. The key question for a practical application of PK-PD models is the ability to estimate the model parameters using patients data. In [1] a novel approach to an accurate quantification of the uncertainty in parameter estimates attributed to inter-individual variability is proposed. The analyzed PK-PD model is formulated as a compartmental ODE system. The methodology of recognizing and capturing the uncertainty in predicted quantities of interest due to inter-individual variability when the individual is not available for repeated measurements may prove to be invaluable in the risk assessment of future experiments and drug applications. Anticancer molecular PK-PD in a cell population dynamics model with drug delivery optimisation is discussed in [2]. The works [3] and [4] deal with various aspects of hemostasis modelling, and [5] with metabolic aspects in a whole-body setting. These studies represent the diversity of aspects of PK-PD modelling nowadays: theoretical about parameter estimation in general versus applied to medical questions in particular, localised cell population versus whole-body settings, cell population and whole-body versus patient population settings.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call